Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Formoterol (6mcg) + Fluticasone Propionate (250mcg)
Dosage Form : Inhaler
Packaging Type : Metered Dose with Carton and Leaflet
Packaging : 120
Price : ₹848/-
Flutialfa F 250 Inhaler is a combination medication that contains Formoterol (6mcg), a long-acting beta-agonist (LABA), and Fluticasone Propionate (250mcg), a potent corticosteroid. This inhaler is specifically designed for the management of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). Formoterol works by relaxing the muscles of the airways, allowing them to open up, which helps improve airflow to the lungs. Fluticasone Propionate reduces inflammation within the airways, preventing the occurrence of asthma attacks or exacerbations in COPD patients.
The combination of these two medications in Flutialfa F 250 Inhaler ensures both long-term bronchodilation and anti-inflammatory effects, providing a comprehensive treatment for patients with asthma and COPD. This inhaler is used as a maintenance therapy to control symptoms, reduce the frequency of exacerbations, and improve overall lung function. It is not intended for immediate relief of acute asthma attacks or COPD flare-ups.
Common side effects include headache, throat irritation, hoarseness, and tremors. Rare but serious side effects may include oral candidiasis (thrush), heart palpitations, or signs of an allergic reaction (rash, swelling).
Flutialfa F 250 Inhaler is indicated for: Asthma: Maintenance treatment for asthma in adults and children (over 12 years) to prevent symptoms and improve lung function. Chronic obstructive pulmonary disease (COPD): Used to reduce exacerbations and manage chronic symptoms of COPD.
This inhaler is for maintenance therapy only and should not be used to relieve acute symptoms. Rinse your mouth after each use to prevent oral thrush. If symptoms persist or worsen, consult your healthcare provider immediately.
Store Flutialfa F 250 Inhaler in a cool, dry place at room temperature (between 15°C to 30°C). Keep the inhaler away from direct sunlight and moisture. Do not refrigerate or freeze the inhaler. Keep it out of the reach of children.
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Salmeterol (50mcg) + Fluticasone Propionate (500 mcg)
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Mometasone (50mcg)
Composition : Fluticasone Furoate (50mcg)
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Formoterol (12mcg) + Tiotropium (18mcg)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
Composition : Tiotropium (9mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation